Delray Beach, FL, April 22, 2025 (GLOBE NEWSWIRE) — The global US Healthcare Analytics Market, valued at US$15.84 billion in 2024, is forecasted to grow at a robust CAGR of 24.5%, reaching US$47.40 billion by 2029. The major factors driving the market growth of the healthcare analytics in the US include growing pressure to curb healthcare spending, increasing demand to improve patient outcomes, and the rising focus on real-world evidence. The Centers for Medicare & Medicaid Services (CMS) projects that from 2023 to 2032, National Health Expenditures will grow at an average annual rate of 5.6%, outpacing GDP growth (4.3%), increasing the health spending share of GDP from 17.3% in 2022 to 19.7% by 2032. The healthcare analytics help to curb this rising healthcare costs by enabling data-driven decision-making, predictive modeling, fraud detection, and optimized resource utilization, reducing unnecessary procedures, hospital readmissions, and inefficiencies in care delivery.
Moreover, several venture capitalists are currently funding US based healthcare analytics startups. For instance, in 2023, US venture capital investments in AI healthcare companies totalled USD 7.2 billion, accounting for 21% of total VC healthcare investment.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=905
Browse in-depth TOC on “US Healthcare Analytics Market“
150 – Tables
50 – Figures
Based on type, the descriptive analytics segment is projected to account for the largest share of US healthcare analytics market in 2023.
The rising need for data-driven decision-making based on historical trends is a key factor propelling the market growth. To extract meaningful insights from past data, organizations increasingly rely on descriptive analytics which further …